Precision medicine is the future of cognitive health — and in this episode, we break down why.Today we’re diving into the ReCODE 2.0 protocol, the case studies behind it, and what recent clinical trials reveal about reversing cognitive decline through a personalized, systems-based approach.For decades, dementia care has focused on symptom management. ReCODE flips that model by identifying and addressing the underlying drivers of decline — metabolic dysfunction, inflammation, nutrient deficiencies, sleep disruption, toxic burden, and more.In this episode, we discuss: • What the ReCODE 2.0 protocol actually involves • Case study outcomes and what “reversal” really means • Why precision medicine is different from one-size-fits-all treatment • How metabolic health plays a central role in cognition • Why early intervention changes everythingWe also review the most recent randomized controlled trial data and what it means for the future of Alzheimer’s prevention and treatment.2025 ReCODE Trial (Referenced in this episode):🔗 https://www.apollohealthco.com/rct-2025/2022 Trial Referenced in the Podcast:🔗 https://www.apollohealthco.com/alzheimers-reversal/If you’re concerned about your cognitive future, watching a loved one decline, or simply want to build a higher standard for your brain, this conversation matters.You do not have to wait for a diagnosis to act. Early signals are information — and precision action can change outcomes.⸻Start Building Your Brain StandardDownload my free guide:🔗 15 Daily Steps to Heal Your Brainhttps://www.bradleyhealthcoaching.com/15-daily-steps464032This is The Brain Standard — where we stop drifting and start building cognitive resilience with intention.Subscribe for more conversations on brain health, metabolism, prevention, and ending Alzheimer’s and dementia.